Marianne P. Allen

Array ( [id] => 3007424 [patent_doc_number] => 05330971 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-19 [patent_title] => 'Growth hormone fusion proteins, methods of production, and methods of treatment' [patent_app_type] => 1 [patent_app_number] => 7/646616 [patent_app_country] => US [patent_app_date] => 1991-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5619 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/330/05330971.pdf [firstpage_image] =>[orig_patent_app_number] => 646616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2929063 [patent_doc_number] => 05232847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-03 [patent_title] => 'Human tissue plasminogen activator analogue having substitutions at amino acid positions 66, 67 and 68' [patent_app_type] => 1 [patent_app_number] => 7/613908 [patent_app_country] => US [patent_app_date] => 1990-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 7 [patent_no_of_words] => 8890 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/232/05232847.pdf [firstpage_image] =>[orig_patent_app_number] => 613908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2919863 [patent_doc_number] => 05206354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-27 [patent_title] => 'DNA sequence encoding active fragment of fibroblast growth factor, HBF-2' [patent_app_type] => 1 [patent_app_number] => 7/615207 [patent_app_country] => US [patent_app_date] => 1990-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7201 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/206/05206354.pdf [firstpage_image] =>[orig_patent_app_number] => 615207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2889169 [patent_doc_number] => 05210028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-05-11 [patent_title] => 'Process for the production of unfused IGF-II protein in E. coli' [patent_app_type] => 1 [patent_app_number] => 7/616470 [patent_app_country] => US [patent_app_date] => 1990-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 8068 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/210/05210028.pdf [firstpage_image] =>[orig_patent_app_number] => 616470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2893656 [patent_doc_number] => 05244806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-14 [patent_title] => 'DNA encoding novel tissue plasminogen activator derivatives having kringles 1 and 2 deleted, vectors and host cells' [patent_app_type] => 1 [patent_app_number] => 7/614966 [patent_app_country] => US [patent_app_date] => 1990-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 26745 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/244/05244806.pdf [firstpage_image] =>[orig_patent_app_number] => 614966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3512977 [patent_doc_number] => 05512433 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-30 [patent_title] => 'Methods and compounds for labeling DNA with xanthine and lower alkyl substituted xanthine derivatives and reagents for the in situ detection of chromosomes' [patent_app_type] => 1 [patent_app_number] => 7/611305 [patent_app_country] => US [patent_app_date] => 1990-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9910 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/512/05512433.pdf [firstpage_image] =>[orig_patent_app_number] => 611305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3019172 [patent_doc_number] => 05326700 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-05 [patent_title] => 'DNA sequences encoding t-PA derivatives with cleavable sites' [patent_app_type] => 1 [patent_app_number] => 7/609510 [patent_app_country] => US [patent_app_date] => 1990-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18445 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/326/05326700.pdf [firstpage_image] =>[orig_patent_app_number] => 609510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2678136 [patent_doc_number] => 05045315 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-09-03 [patent_title] => 'Process for treating thrombosis by administering poly-kringle plasminogen activator' [patent_app_type] => 1 [patent_app_number] => 7/601542 [patent_app_country] => US [patent_app_date] => 1990-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 14 [patent_no_of_words] => 10598 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/045/05045315.pdf [firstpage_image] =>[orig_patent_app_number] => 601542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2937208 [patent_doc_number] => 05223256 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-29 [patent_title] => 'Thrombolytically active non-glycosylated protein' [patent_app_type] => 1 [patent_app_number] => 7/585129 [patent_app_country] => US [patent_app_date] => 1990-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6979 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/223/05223256.pdf [firstpage_image] =>[orig_patent_app_number] => 585129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3070739 [patent_doc_number] => 05364769 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-15 [patent_title] => 'Nucleic acid encoding neurotrophic factor four (NT-4), vectors, host cells and methods of production' [patent_app_type] => 1 [patent_app_number] => 7/587707 [patent_app_country] => US [patent_app_date] => 1990-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13533 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/364/05364769.pdf [firstpage_image] =>[orig_patent_app_number] => 587707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3607097 [patent_doc_number] => 05589361 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Human tissue-type plasminogen activator variant' [patent_app_type] => 1 [patent_app_number] => 7/581189 [patent_app_country] => US [patent_app_date] => 1990-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 9346 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589361.pdf [firstpage_image] =>[orig_patent_app_number] => 581189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2929777 [patent_doc_number] => 05219759 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Recombinant DNA encoding PDGF A-chain polypeptide and expression vectors' [patent_app_type] => 1 [patent_app_number] => 7/574540 [patent_app_country] => US [patent_app_date] => 1990-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9752 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219759.pdf [firstpage_image] =>[orig_patent_app_number] => 574540 [rel_patent_id] =>[rel_patent_doc_number] =>)